Literature DB >> 1093657

Comparative efficacy of ampicillin and trimethoprim-sulfamethoxazole in otitis media.

G G Cameron, A C Pomahac, M T Johnston.   

Abstract

Seventy-nine children with acute otitis media were the subjects in a study designed to compare the effectiveness of ampicillin and trimethoprim-sulfamethoxazole in this infection. They received either of these two agents according to a double-blind randomized procedure that also took the child's weight into account. No significant difference was found in the clinical outcome between the two treatment regimens. Undesirable side effects from TMP-SMX were notably few.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093657      PMCID: PMC1956439     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.

Authors:  E B Lewin; J O Klein; M Finland
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  The use of 'Septrin' in the treatment of upper respiratory-tract infections.

Authors:  E Mallett; D Musselwhite
Journal:  Practitioner       Date:  1970-12

3.  Etiology of acute otitis media in infants and children.

Authors:  O E Laxdal; R M Blake; T Cartmill; H E Robertson
Journal:  Can Med Assoc J       Date:  1966-01-22       Impact factor: 8.262

  3 in total
  3 in total

1.  The optimum pH for the derivative spectrophotometric determination of co-trimoxazole in binary mixtures.

Authors:  R O Adome; S Balyejjusa
Journal:  Afr Health Sci       Date:  2002-12       Impact factor: 0.927

Review 2.  Common bacterial infections in infancy and childhood. 1. Respiratory infections.

Authors:  H C Spratt; G A Ahronheim; M I Marks
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.